Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KN060 in ESRD Patients on Hemodialysis
NCT07201467Phase 2Recruiting
- Sponsor
- Alphamab Oncology
- Start
- Aug 2025
- Primary completion
- Aug 2027
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of lofacimig in thrombosis, sponsored by Alphamab Oncology. Started Aug 2025; status: recruiting.
02
Drugs
lofacimig
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT07201467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07201467.